| Polypharmacy | Dementia | Fit | Very severe |  |
---|---|---|---|---|---|
Cluster N | 1 | 2 | 3 | 4 | p |
N | 155 | 149 | 176 | 121 | Â |
Age (years), mean(SD) | 83.2 (6.6) | 86.7 (6.4) | 82.1 (7.5) | 85.2 (6.2) | 0.859 |
Sex (Female), n (%) | 120 (77%) | 125 (84%) | 147 (84%) | 98 (81%) | 0.427 |
Dementia, n(%) | 21 (14%) | 129 (87%) | 22 (12%) | 108 (89%) | < 0.001 |
ADL, median(IQR) | 5 (4–6) | 2 (1–3) | 6 (5–6) | 1 (1–2) | < 0.001 |
Delirium in 72h after surgery, n(%) | 22 (14%) | 114 (77%) | 21 (12%) | 98 (81%) | < 0.001 |
Polypharmacy >5 at admission, n(%) | 155 (100%) | 0 (0%) | 0 (0%) | 121 (100%) | < 0.001 |
Hospitalization length, median (IQR) | 11 (8–14) | 9 (7–12) | 9 (7–12) | 10 (7–14) | < 0.001 |
MNA, n(%) | Â | Â | Â | Â | < 0.001 |
 Well-nourished | 58 (40%) | 14 (10%) | 72 (43%) | 15 (13%) | |
 At risk | 73 (50%) | 96 (70%) | 80 (48%) | 76 (68%) | |
 Malnourished | 15 (10%) | 28 (20%) | 16 (10%) | 21 (19%) | |
CCI, median(IQR) | 5 (4–7) | 6 (5–7) | 4 (4–6) | 6 (5–8) | < 0.001 |
Diabetes Mellitus, n(%) | 42 (27%) | 31 (21%) | 17 (10%) | 32 (27%) | < 0.001 |
CKD (Moderate-severe), n(%) | 20 (13%) | 19 (13%) | 9 (5%) | 26 (22%) | < 0.001 |
CHF, n(%) | 20 (13%) | 16 (11%) | 14 (8%) | 19 (16%) | 0.2 |
Myocardial Infarction, n(%) | 29 (19%) | 22 (15%) | 7 (4%) | 30 (25%) | < 0.001 |
COPD, n(%) | 18 (12%) | 11 (7%) | 13 (7%) | 10 (8%) | 0.472 |
Peripheral vascular disease, n(%) | 29 (19%) | 22 (15%) | 21 (12%) | 15 (12%) | 0.274 |
ADL disabilitya, n(%) | 47 (30%) | 138 (93%) | 24 (14%) | 112 (93%) | < 0.001 |
Setting at discharge, n(%) | Â | Â | Â | Â | 0.125 |
 Home | 56 (43%) | 43 (38%) | 46 (30%) | 36 (43%) | |
 Rehabilitation | 75 (57%) | 70 (62%) | 105 (70%) | 48 (57%) | |
N Drugs at admission, median(IQR) | 8 (7–9) | 4 (2–5) | 3 (2–4) | 7 (6–9) | < 0.001 |